Rosenblum Silverman Sutton’s Celgene Corp CELG Stock Holding History
Bought
Maintained
Sold
Other funds holding CELG
OAG
PCM
Rosenblum Silverman Sutton's CELG Position: Q1 2019 in Review
Rosenblum Silverman Sutton sold out of Celgene Corp (CELG) in Q1 2019, closing a stake of 6,069 shares — an estimated $660K sold.
Rosenblum Silverman Sutton first reported a position in CELG in Q3 2013 and held it in 20 quarters. The position peaked at $9.84M in Q3 2017. 1,389 funds tracked by Wall St. Rank hold CELG as of Q1 2019.
- Rosenblum Silverman Sutton reported no remaining Celgene Corp position as of Q1 2019 after selling out during the quarter.
- Rosenblum Silverman Sutton sold 6,069 Celgene Corp shares in Q1 2019, an estimated $660K.
- Rosenblum Silverman Sutton first reported a position in Celgene Corp in Q3 2013 and held it in 20 quarters.
- Rosenblum Silverman Sutton's Celgene Corp position peaked at $9.84M in Q3 2017.
- 1,389 funds tracked by Wall St. Rank held Celgene Corp as of Q1 2019.
Based on Rosenblum Silverman Sutton's 13F filing for Q1 2019, filed 25 Apr 2019.